ARTICLE | Clinical News
NicOx to start Phase II
April 20, 2000 7:00 AM UTC
NicOx (NM:Nicox) said it will begin a 24-patient U.K. Phase II trial of HCT-1026 to treat urinary incontinence. HCT-1026 is a nitric oxide-releasing non-steroidal anti-inflammatory drug. ...